Harvard Bioscience

(NASDAQ) HBIO

Current Price$6.21

Market Cap$28.84M

Since IPO (2000)-92%

5 Year-91%

1 Year+69%

1 Month+32%

Harvard Bioscience Financials at a Glance

Market Cap

$28.84M

Revenue (TTM)

$86.55M

Net Income (TTM)

$56.70M

EPS (TTM)

$-12.85

P/E Ratio

-0.50

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$6.21

Volume

171

Open

$6.27

Price

$6.21

Volume

171

Open

$6.27

Previous Close

$6.45

Daily Range

$6.21 - $6.27

52-Week Range

$2.81 - $9.46

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$6.21

Volume

171

Open

$6.27

Previous Close

$6.45

Daily Range

$6.21 - $6.27

52-Week Range

$2.81 - $9.46

HBIO News

Harvard Bioscience Tops Q2 Revenue Views

Motley Fool Markets TeamAug 11, 2025

Why Harvard Bioscience Stock Rose This Week

James HalleyApr 27, 2023

I’m Selling Harvard Biosciences

Jim RoyalMar 27, 2014

Why Harvard Bioscience Is Poised to Pop

BRIAN PACAMPARAJan 22, 2013

I'm Putting Real Money on Harvard Bioscience

Jim RoyalJan 18, 2013

Here's How Harvard Bioscience May Be Failing You

Seth JaysonAug 1, 2011

5-Star Stocks Poised to Pop: Harvard Bioscience

BRIAN PACAMPARAApr 26, 2011

Tomorrow's Monster Stock?

Rich DupreyMar 31, 2011

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Harvard Bioscience

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

339

CEO

John D. Duke, MBA

Website

www.harvardbioscience.com

Headquarters

Holliston, MA 01746, US

HBIO Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

-56%

Net Income Margin

-66%

Return on Equity

-147%

Return on Capital

-83%

Return on Assets

-71%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.84M

Shares Outstanding

4.47M

Volume

171

Avg. Volume

61.02K

Financials (TTM)

Gross Profit

$45.88M

Operating Income

$629.00K

EBITDA

$5.32M

Operating Cash Flow

$6.73M

Capital Expenditure

$1.11M

Free Cash Flow

$5.62M

Cash & ST Invst.

$8.61M

Total Debt

$44.28M

Harvard Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$23.73M

-3.3%

Gross Profit

$11.31M

-19.3%

Gross Margin

47.64%

N/A

Market Cap

$28.84M

N/A

Market Cap/Employee

$87.41K

N/A

Employees

330

N/A

Net Income

$2.85M

-15916.7%

EBITDA

$52.34M

+1534.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$35.66M

+11.7%

Accounts Receivable

$16.04M

+7.9%

Inventory

$20.80M

-10.5%

Long Term Debt

$42.75M

+570.0%

Short Term Debt

$1.52M

-96.0%

Return on Assets

-70.81%

N/A

Return on Invested Capital

-83.23%

N/A

Free Cash Flow

$545.00K

-143.3%

Operating Cash Flow

$96.00K

-105.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RVPRetractable Technologies, Inc.

RVPRetractable Technologies, Inc.$0.62-1.38%

TAOXTAO Synergies Inc.

TAOXTAO Synergies Inc.$4.85-3.96%

NCNANuCana plc

NCNANuCana plc$2.02-6.05%

COSMCosmos Health Inc.

COSMCosmos Health Inc.$0.36-3.16%

FEMYFemasys Inc.

FEMYFemasys Inc.$0.36-2.14%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

NXLNexalin Technology, Inc.

NXLNexalin Technology, Inc.$0.35-5.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$15.73-0.14%

NOKNokia

NOKNokia$12.59+0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.20+0.05%

POETPoet Technologies

POETPoet Technologies$6.45-0.20%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.68+0.39%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.09+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.84-0.02%

Questions About HBIO

What is the current price of Harvard Bioscience?

Harvard Bioscience is trading at $6.21 per share.

What is the 52-week range for Harvard Bioscience?

Over the past 52 weeks, Harvard Bioscience has traded between $2.81 and $9.46.

How much debt does Harvard Bioscience have?

As of the most recent reporting period, Harvard Bioscience reported total debt of $44.28M.

How much cash does Harvard Bioscience have on hand?

Harvard Bioscience reported $8.61M in cash and cash equivalents in its most recent financial results.

What is Harvard Bioscience’s dividend yield?

Harvard Bioscience does not currently have a dividend yield.

Harvard Bioscience

Harvard Bioscience Financials at a Glance

HBIO News

Harvard Bioscience Tops Q2 Revenue Views

Why Harvard Bioscience Stock Rose This Week

I’m Selling Harvard Biosciences

Why Harvard Bioscience Is Poised to Pop

I'm Putting Real Money on Harvard Bioscience

Here's How Harvard Bioscience May Be Failing You

5-Star Stocks Poised to Pop: Harvard Bioscience

Tomorrow's Monster Stock?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Harvard Bioscience

HBIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Harvard Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HBIO

What is the current price of Harvard Bioscience?

What is the 52-week range for Harvard Bioscience?

How much debt does Harvard Bioscience have?

How much cash does Harvard Bioscience have on hand?

What is Harvard Bioscience’s dividend yield?

Premium Investing Services